Ocular Therapeutix
OCUL
OCUL
75 hedge funds and large institutions have $70.2M invested in Ocular Therapeutix in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
4.08% less ownership
Funds ownership: 53% → 48.92% (-4.1%)
30% less capital invested
Capital invested by funds: $99.9M → $70.2M (-$29.7M)
Holders
75
Holding in Top 10
4
Calls
$506K
Puts
$441K
Top Buyers
| 1 | +$1.8M | |
| 2 | +$813K | |
| 3 | +$423K | |
| 4 |
BlackRock
New York
|
+$403K |
| 5 |
State Street
Boston,
Massachusetts
|
+$280K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$843K | |
| 3 | -$756K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$532K |
| 5 |
SCM
Sio Capital Management
New York
|
-$263K |